Epidemiology of sepsis in cancer patients in Victoria, Australia: a population‐based study using linked data

Abstract

ObjectiveTo determine the clinical characteristics, outcomes and longitudinal trends of sepsis occurring in cancer patients. MethodRetrospective study using statewide Victorian Cancer Registry data linked to various administrative datasets. ResultsAmong 215,763 incident cancer patients, incidence of sepsis within one year of cancer diagnosis was estimated at 6.4%. The incidence of sepsis was higher in men, younger patients, patients diagnosed with haematological malignancies and those with de novo metastatic disease. Of the 13,316 patients with a first admission with sepsis, 55% had one or more organ failures, 29% required care within an intensive care unit and 13% required mechanical ventilation. Treatments associated with the highest sepsis incidence were stem cell/bone marrow transplant (33%), major surgery (4.4%), chemotherapy (1.1%) and radical radiotherapy (0.6%). The incidence of sepsis with organ failure increased between 2008 and 2015, while 90‐day mortality decreased. ConclusionsSepsis in patients with cancer has high mortality and occurs most frequently in the first year after cancer diagnosis. Implications for public healthThe number of cancer patients diagnosed with sepsis is expected to increase, causing a substantial burden on patients and the healthcare system.